The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs offer a lifeline to small medical technology companies that otherwise would not be able to secure the initial funding necessary for expensive research and development.
Tonix Pharmaceuticals Announces Trial Design of New Phase 2 Clinical Study of TNX-1300 for Cocaine Intoxication
Montana’s Tonix Pharmaceuticals has announced the design of a new Phase 2 clinical trial of TNX-1300 for the treatment of cocaine intoxication. This new protocol has the potential to serve as a pivotal trial. TNX-1300 is a recombinant enzyme that efficiently degrades and metabolizes cocaine in cocaine users, as demonstrated in a prior Phase 2a randomized, double-blind, placebo-controlled clinical study, providing support of the use of TNX-1300 as a treatment for cocaine intoxication. The company plans to submit the new protocol to the U.S. Food and Drug Administration (FDA).
Bio.News: Coverage for a Growing Industry
Covid-19 opened the world’s eyes to the wonders of biotechnology. Unfortunately, though, coverage of the industry isn’t always the best. To provide more information about the ways bioscience is curing disease, solving climate change, and feeding and fueling the world in more sustainable ways, the Montana BioScience Alliance is joining with BIO to develop easy-to-read and easy-to-share news articles by independent journalists, editors, and content creators, as well as smart analysis by BIO experts. You can find it now on Bio.News.
House Appropriations Committee Prioritizes Medical Research with Significant Increase for NIH in FY 2023 Budget
The House Appropriations Committee has approved its FY 2023 spending bill including a $2.5 billion funding increase for the National Institutes of Health (NIH), a $466 million funding boost for the National Cancer Institute (NCI) and $2.75 billion for the Advanced Research Projects Agency on Health (ARPA-H). The bill increases current funding levels for the Centers for Disease Control and Prevention (CDC) cancer screening and early detection programs and for the CDC’s Office on Smoking and Health, which provides funding for programs that help prevent youth from starting to use tobacco and helps adult tobacco users to quit.
Golden Helix: Providing Leading Genomic Data Analysis Software
Although you may not consider Montana a center of biotechnology, Golden Helix has proven time and again how they are able to expand their influence and impact on the biotech community amid the scenic Northwest. The software company is a leader in Next-Gen Sequencing DNA software and supports the creation of clinical reports in the cancer and inherited disease spaces. Their technologies and analytics continue to empower scientists and healthcare professionals to derive meaning from their vast amounts of data. Here is how Golden Helix got to where it is today and where they plan on going.
Overcoming Barriers to Biomarker Testing to Improve Outcomes for Cancer Patients
Biomarker testing helps connect patients with the most effective treatments for their cancer – but not all patients are benefiting from the latest advances in cancer treatment. Learn how biomarker testing helps cancer patients and what can be done to improve access and advance health equity.
Inimmune’s new CEO Alan Joslyn takes the helm
Inimmune Corp., a leader in developing the next generation of vaccines and immunotherapeutics, announced today that Dr. Alan Joslyn has been appointed President and Chief Executive Officer of the company. Dr. Joslyn will also join the Inimmune Board of Directors as CEO.
America can’t get caught flat-footed on pandemics again
How did the United States, a global superpower, get caught so flatfooted when the COVID-19 pandemic hit? A big reason was sleeping through the decline of domestic pharmaceutical manufacturing, allowing most development and manufacturing capabilities and jobs to leave the U.S. for foreign countries.
What’s hot in life sciences? Bio International Convention looks at what’s next as pandemic recedes
Bio event draws about 3,000 companies to the San Diego Convention Center to take stock of the latest trends and research.
Olympian and Grand Slam Champion Venus Williams and Sportscasting Legend Erin Andrews Share Their Patient Perspectives with Biotech Community 
Four-time gold medalist and seven-time Grand Slam singles champion Venus Williams will discuss her groundbreaking career, business success, and prioritizing health in a conversation moderated by Emmy-nominated sports reporter Erin Andrews at the BIO International Convention June 13-16, 2022, in San Diego. Both women have faced their own health challenges, becoming advocates for increased awareness and better outcomes for all.